Literature DB >> 27261369

Modeling simple repeat expansion diseases with iPSC technology.

Edyta Jaworska1, Emilia Kozlowska1, Pawel M Switonski1, Wlodzimierz J Krzyzosiak2.   

Abstract

A number of human genetic disorders, including Huntington's disease, myotonic dystrophy type 1, C9ORF72 form of amyotrophic lateral sclerosis and several spinocerebellar ataxias, are caused by the expansion of various microsatellite sequences in single implicated genes. The neurodegenerative and neuromuscular nature of the repeat expansion disorders considerably limits the access of researchers to appropriate cellular models of these diseases. This limitation, however, can be overcome by the application of induced pluripotent stem cell (iPSC) technology. In this paper, we review the current knowledge on the modeling of repeat expansion diseases with human iPSCs and iPSC-derived cells, focusing on the disease phenotypes recapitulated in these models. In subsequent sections, we provide basic practical knowledge regarding iPSC generation, characterization and differentiation into neurons. We also cover disease modeling in iPSCs, neuronal stem cells and specialized neuronal cultures. Furthermore, we also summarize the therapeutic potential of iPSC technology in repeat expansion diseases.

Entities:  

Keywords:  Neurodegeneration; Neurons; Pluripotent cells; PolyQ diseases; TRED; Triplet repeat expansion

Mesh:

Year:  2016        PMID: 27261369     DOI: 10.1007/s00018-016-2284-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  112 in total

1.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

2.  Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells.

Authors:  Yee-Ki Lee; Philip Wing-Lok Ho; Revital Schick; Yee-Man Lau; Wing-Hon Lai; Ting Zhou; Yanhua Li; Kwong-Man Ng; Shu-Leung Ho; Miguel Angel Esteban; Ofer Binah; Hung-Fat Tse; Chung-Wah Siu
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

3.  Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.

Authors:  Ningzhe Zhang; Mahru C An; Daniel Montoro; Lisa M Ellerby
Journal:  PLoS Curr       Date:  2010-10-28

4.  Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration.

Authors:  Zihui Xu; Mickael Poidevin; Xuekun Li; Yujing Li; Liqi Shu; David L Nelson; He Li; Chadwick M Hales; Marla Gearing; Thomas S Wingo; Peng Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-03       Impact factor: 11.205

5.  Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.

Authors:  Feng-Lan Chiu; Jun-Tasi Lin; Ching-Yu Chuang; Ting Chien; Chiung-Mei Chen; Kai-Hsiang Chen; Han-Yun Hsiao; Yow-Sien Lin; Yijuang Chern; Hung-Chih Kuo
Journal:  Hum Mol Genet       Date:  2015-08-11       Impact factor: 6.150

6.  Retinoic acid functions as a key GABAergic differentiation signal in the basal ganglia.

Authors:  Christina Chatzi; Thomas Brade; Gregg Duester
Journal:  PLoS Biol       Date:  2011-04-12       Impact factor: 8.029

Review 7.  Advances in mechanisms of genetic instability related to hereditary neurological diseases.

Authors:  Robert D Wells; Ruhee Dere; Micheal L Hebert; Marek Napierala; Leslie S Son
Journal:  Nucleic Acids Res       Date:  2005-07-08       Impact factor: 16.971

8.  Friedreich's ataxia--a case of aberrant transcription termination?

Authors:  Jill Sergesketter Butler; Marek Napierala
Journal:  Transcription       Date:  2015-04-01

9.  A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity.

Authors:  Yuwei Yao; Xiaotian Cui; Ismael Al-Ramahi; Xiaoli Sun; Bo Li; Jiapeng Hou; Marian Difiglia; James Palacino; Zhi-Ying Wu; Lixiang Ma; Juan Botas; Boxun Lu
Journal:  Elife       Date:  2015-03-04       Impact factor: 8.140

Review 10.  RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders.

Authors:  Marzena Wojciechowska; Marta Olejniczak; Paulina Galka-Marciniak; Magdalena Jazurek; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2014-09-12       Impact factor: 16.971

View more
  5 in total

1.  Progress in understanding Friedreich's ataxia using human induced pluripotent stem cells.

Authors:  Anna M Schreiber; Julia O Misiorek; Jill S Napierala; Marek Napierala
Journal:  Expert Opin Orphan Drugs       Date:  2019-01-09       Impact factor: 0.694

Review 2.  Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools.

Authors:  Marianna Karwacka; Marta Olejniczak
Journal:  Cells       Date:  2022-02-02       Impact factor: 6.600

Review 3.  Regulatory Potential of Competing Endogenous RNAs in Myotonic Dystrophies.

Authors:  Edyta Koscianska; Emilia Kozlowska; Agnieszka Fiszer
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

4.  RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and Replacement.

Authors:  Aida Abu-Baker; Nawwaf Kharma; Jonathan Perreault; Alanna Grant; Masoud Shekarabi; Claudia Maios; Michele Dona; Christian Neri; Patrick A Dion; Alex Parker; Luc Varin; Guy A Rouleau
Journal:  Mol Ther Nucleic Acids       Date:  2019-02-15

5.  Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.

Authors:  Magdalena Dabrowska; Agata Ciolak; Emilia Kozlowska; Agnieszka Fiszer; Marta Olejniczak
Journal:  Int J Mol Sci       Date:  2020-03-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.